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Cell–cell contacts play important roles in the homeostasis of normal epithelium and in the steps of metastasis of tumor cells, although signaling
mechanisms to regulate cell–cell contacts are unclear. In this study, we observed that phenotype of no cell–cell contacts in rat intestinal epithelial
cell subline (RIE1-Sca) correlated with increased Erk1/2 signaling activity, compared to that of parental RIE1 cells growing in colonies.
Furthermore, cell–cell contacts between RIE1-Sca cells were reformed by treatment with a specific MEK inhibitor (U0126), with translocation of
ZO1 and β-catenin to cell–cell contacts, without changes of their expression levels. U0126 treatment also increased EGFR phosphorylation in a
ligand-independent manner. Pretreatment with EGFR kinase inhibitor abolished U0126 treatment-mediated EGFR phosphorylation, and
expression of dominant negative H-Ras N17 allowed EGFR phosphorylation and cell–cell contacts even without U0126 treatment. Furthermore,
the expression of a nonphosphorylatable EGFR Y5F mutant abolished U0126-mediated cell–cell contacts. U0126 treatment also caused less
efficient wound healing by keeping monolayer integrity intact, compared to control untreated cells. This U0126-mediated reduction in wound
healing was further altered either by pretreatment of EGFR kinase inhibitor or expression of H-Ras N17 or EGFR Y5F. Taken together, this study
supports a unique mechanism of cell–cell contact formation through MEK/Erks inhibition-mediated EGFR phosphorylation.
© 2007 Elsevier B.V. All rights reserved.Keywords: Erk; EGFR; Cell–cell contacts; wound healing1. Introduction
The architectural integrity of the adhesive epithelial mono-
layer is maintained by integrin engagement to extracellular
matrix (ECM) proteins at basal membranes and cell–cell
contacts between a cell and adjacent cells [1]. Disruption of this
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doi:10.1016/j.bbamcr.2007.02.003epithelium but also allows the dissemination of cancerous cells
from the primary tumor bodies during the early steps of cancer
metastasis [2,3]. Moreover, the dissemination of individual
cells from epithelial monolayer involves a transition of
epithelial cell types with well-established cell contacts to
mesenchymal-like cells (i.e., elongated spindle-type cells) with
few or no cell contacts [4]. This loss of cell–cell contacts is
important clinically, since disseminated tumor cells might be
facilitated in cell migration and invasion leading to tumor
metastasis [3,5]. Therefore, it is interesting to reveal the
mechanisms of how cell–cell contact loss can involve the
regulation of intracellular signal transduction and the suppres-
sion of E-cadherin [6].
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linked to intracellular actin filaments through diverse protein–
protein interactions [1]. Therefore, epithelial monolayer
integrity and intracellular actin organization influence each
other bi-directionally. That is, the disruption of cell–cell
contacts can cause alterations in actin organization, and
conversely abnormal actin organization can cause changes in
cell contact status [7]. In addition, several signaling molecules
stimulated by integrin receptor, growth factor receptor, or cross-
talks between these receptors are known to be involved in the
regulation of cell–cell contact formation [6]. These molecules
include focal adhesion kinase (FAK), c-Src family kinase [6],
Rho GTPases [8], Akt/PKB [9], Ras/Raf1/MEK/Erks cascade
[10,11], c-Met [12], and others. That is, the activation of these
molecules disrupts cell–cell contacts, by releasing E-cadherin,
β-catenin, and zonula occludens-1 (ZO1) from cell–cell contact
sites [13].
Meanwhile, the opposite phenomenon, namely, cell–cell
contact formation may also be clinically important, as normal
epithelial cells maintain homeostasis at a monolayer integrity
and tumor cells that have moved from primary tumor bodies to
other distal sites through lymph nodes or blood vessels would
undergo cell–cell contact formation and acquire growth for
metastatic tumors [3]. However, the manner in which cells form
cell–cell contacts via the regulation of intracellular signaling
pathways beyond the regulation of E-cadherin expression is
largely unknown. It has been shown that the disruption or
inhibition of the signaling activities of the molecules respon-
sible for cell–cell contact loss leads to the abolishment of the
loss. However, it is not known whether such disruptions and
inhibitions always cause formation of cell–cell contacts.
Moreover, an understanding of the mechanisms of cell–cell
contact formation could lead to the development of reagents or
strategies not to allow dissemination of tumor cells from
primary tumors and to deal with settle-down for metastatic
tumors.
In this study, we used a normal rat intestinal epithelial sub-
cell line growing in a scattered pattern (RIE1-Sca) to examine
how scattered-growth patterns can be converted to colony-
forming patterns. We observed that the inhibition of the Ras/
Raf1/MEK/Erks cascade reverted the scattered to colony-
forming patterns and this revert required phosphorylation of
EGFR. Therefore, the Ras/Erks cascade inhibition-mediated
phosphorylation of EGFR appears to be important for cell–cell
contact formation in the normal rat epithelial cell system.2. Materials and methods
2.1. Cells
RIE1-Sca cells growing in a scattered pattern were prepared by selection and
enrichment from normal rat intestinal epithelial (RIE1) cells growing in a
colony-forming pattern. The multiple clones with scattered-growing patterns
were selected and mixed prior to enrichment. Subculture of the RIE1-Sca cells
showed consistently scattered-growing patterns, while maintaining cells for 2
months by subculture every 2–3 days. Cells were maintained in DMEM-H
(Gibco-BRL) culture media containing 10% (v/v) fetal bovine serum (FBS) at
37 °C and 5% CO2.2.2. Cell lysates preparation and Western blots
Whole cell lysates from cells treated with DMSO or 20 μM U0126 (LC
Laboratories®,Woburn, MA) for the indicated periods were prepared as described
in previous studies [14, 15]. In cases of EGFR kinase inhibition, AG1478 (LC
Laboratories®) at 1 μMwas treated for the indicated period or pretreated 30 min or
2 h before U0126 treatment for 2 or 14 h. In cases, cells were infected with
retrovirus expressing human H-Ras V12 (active form, a gift from Dr. In-San Kim,
Kyungpook National University, Daegu, Korea), H-Ras N17 (dominant negative
form), or EGFR Y5F for 12 h. After additional incubation for 22 h, cells were
treated with DMSO or 20 μM U0126 for 14 h. In cases, cells were preincubated
with neutralizing anti-EGF (10 μg/ml, Upstate Biotechnology) antibody or serum-
starved overnight prior to U0126 treatment for additional 14 h. After incubations,
cell lysates were prepared and their protein amounts were normalized using
bicinchoninic acid (BCA) Protein Assay Reagent Kits (Pierce, Rockford, IL).
Standard Western blots were performed by using antibodies against phospho-
Y397FAK, phospho-Y577FAK, phospho-Y861FAK, phospho-Y925FAK (BioSource
International Inc., Camarillo, CA), phospho-Y416Src, c-Src, pY1173EGFR, (Santa
Cruz Biotech., Santa Cruz, CA), Erk1/2, phospho-Erk1/2, phospho-S473Akt/PKB,
phospho-Y992EGFR, phospho-Y1045EGFR, phospho-Y1068EGFR (Cell Signaling
Tech., Beverly, MA), E-cadherin, phospho-Tyrosine, FAK, α-tubulin (BD
Transduction Lab., San Jose, CA), vimentin (Sigma, Saint Louis, MI),
Desmoplakin (SerotecLtd., Oxford, UK), ZO1 (ZymedLab., South San Francisco,
CA), or EGFR (Upstate Biotech., Lake Placid, NY).
2.3. Preparation of retroviruses
Human H-Ras V12 in pLNCX vector was used to make dominant negative
H-Ras N17 (DN H-Ras N17) via a PCR approach. pRC/CMV-EGFR-Y5F
construct in which the sites of tyrosine autophosphorylation (tyrosines 992,
1068, 1086, 1148, and 1173) have been mutated to phenylalanines [16] was also
subcloned into a modified pLNCX retroviral vector as a HindIII and XbaI insert.
Sequences of mutants were confirmed by direct sequence analyses. Retroviral
vectors were separately transfected into PT67 packaging cells by using
Lipofectamine 2000® (Life Technologies, Gaithersburg, MD) following the
manufacturer's protocol. Two days after separate transfections, cells were
selected with G418 (250 μg/ml). The culture soup of the stable PT67 cells was
used for retrovirus infections, and reproducible infection rates for similar
expressions of target proteins were confirmed by Western blots.
2.4. Immunofluorescence microscopy
Cells were replated on normal culture media-precoated glass coverslips and
incubated overnight at 37 °C to achieve typical cell adhesion and spreading, as
described previously [17]. In certain cases, cells were pretreated with AG1478
(1 μM) 30 min or 2 h before U0126 (20 μM) treatment for 14 h. Pretreatment of
AG1478 either 30 min or 2 h prior to U0126 treatment resulted in similar results.
In cases, cells were infected with pLNCX-H-Ras V12 or N17 or pLNCX-EGFR
Y5F retroviruses for 12 h. The cells were then normally incubated for an
additional 22 h. Alternatively, cells were preincubated with normal rabbit IgG or
neutralizing anti-EGF (10 μg/ml) 60 min before DMSO or U0126 treatment.
U0126 at 20 μMwas then treated for an additional 14 h to cells infected with H-
Ras N17 or EGFR Y5F. Wounds through cell monolayer on cover glasses were
made as below. Cell images were then taken using a phase contrast microscope or
cells were fixed with 3.7% formaldehyde in PBS for 10 min, permeabilized with
0.5% Triton X-100 in PBS for 10 min at room temperature, and washed three
times with PBS (3 times×10 min). Cells were then incubated with primary
antibody or TRITC-conjugated phalloidin (Molecular Probes, Eugene, OR) for
1 h and washed with PBS as above. The primary antibody used included anti-β-
catenin (Santa Cruz Biotech.) and ZO1 (Zymed Lab. Inc.). Cells were then
incubated with anti-rabbit or mouse IgG-conjugated TRITC or FITC (Chemicon
International, Inc., Temecula, CA) in a dark and humidified chamber for 1 h
Alternatively, cells were stained for actin by using phalloidin-conjugated with
TRITC, as described earlier [17]. After washings three times with PBS as
described above, cells on glass coverslips were mounted with mounting solution
(DakoCytomation, Germany) and visualized by fluorescent microscopy
(BX51TR, Olympus, Japan).
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Cells were seeded and cultured to reach a confluent monolayer with or
without pLNCX-DN H-Ras N17 or pLNCX-EGFR Y5F retrovirus infection.
Wounds were then made by scraping through the cell monolayer with a pipette
tip, before washing twice with DMEM-H containing 10% FBS. In certain cases,
cells were treated with AG1478 EGFR kinase inhibitor at the indicated
concentrations, 20 min before U0126 treatment. After incubation at 37 °C for the
indicated periods, several images around wounds in each condition were taken
and representative wound distance was measured for graphic presentations.
2.6. Statistical analysis
Student's t-tests were performed for comparisons of mean values to see if
the difference is significant. p values ≤0.05 were considered significant.
3. Results
3.1. U0126 treatment–mediated formation of cell–cell contacts
To understand the intracellular signaling mechanisms
responsible for the regulation of cell–cell contacts, we
established a variant cell line (RIE1-Sca) that normally grows
in a scattered pattern, from normal rat intestinal epithelial cells
(RIE1) that grow in a colony-forming manner, with normal actin
organization (Fig. 1A). This was done by repeated selection and
enrichment processes during traditional cultures. RIE1-Sca cells
were more spindle-shaped than the parental RIE1 cells (Fig.
1A). Next, we immunoblotted whole cell extracts prepared from
RIE1-WT or -Sca cells. Among intracellular signaling mole-
cules, we found that phosphorylations of Erk1/2 and Focal
Adhesion Kinase (FAK) Tyr925 (i.e., pY925FAK) were much
enhanced in RIE1-Sca cells, as compared with those of RIE1-
WT cells (Fig. 1B, lines 1 and 3).
We investigated if any pharmacological reagent could
convert the scattered RIE1-Sca cells to colony-forming patterns.
We examined the effects of diverse commercial inhibitors and
activators. U0126, a specific MEK inhibitor, was found to cause
a colony-forming pattern in RIE1-Sca cells through cell–cell
contact formation (Fig. 1C), which is consistent with the
observation of an enhanced Erk1/2 activity in RIE1-Sca cells, as
compared with that in RIE1-WT cells. When treated with
U0126, RIE1-Sca cells showed decreased pY397FAK but no
significant changes in other tyrosine phosphorylations, such as
of pY577FAK, pY861FAK, and pY925FAK (Fig. 1B, lines 3 and
4). In addition, U0126-treatment decreased c-Src phosphoryla-
tion at Tyr416 in RIE1-Sca cells (i.e., pY416c-Src, Fig. 1B, lines
3 and 4). Moreover, these changes appear to be consistent with
previous reports that FAK and c-Src family kinase are involved
in loss of cell–cell contact [6]. Therefore, we next examined
these U0126-mediated effects by immunostaining for ZO1
protein (a marker of tight junctions) [1]. RIE1-Sca cells did not
show cell–cell contacts with ZO1, but ZO1 localization at cell–
cell contacts became obvious after U0126 treatment (Fig. 1D,
upper). In addition, β-catenin (a marker of adherence junctions)
also localized to the cell–cell contacts of RIE1-Sca cells after
U0126 treatment, indicating that cell–cell contact formation
was induced by U0126 treatment in RIE1-Sca cells (Fig. 1D,
lower). Moreover, an enhanced vimentin (a mesenchymalmaker) level in RIE1-Sca, as compared to that in RIE1-WT
cells, was significantly reduced by U0126 treatment (Fig. 1E,
lanes 1 to 3). However, the immunostainings of E-cadherin
(another cell–cell contact marker) in rat cells (i.e., RIE1-Sca)
were failed even when we tried diverse anti-E-cadherin or -pan-
cadherin antibodies and protocols to fix and permeabilize cells,
although the E-cadherin expression was detected unchanged
before and after U0126 treatment (Fig. 1F). Therefore, U0126
treatment of RIE1-Sca cells caused cell–cell contact formation
without altering the expression levels of the cell–cell contact
markers tested.
3.2. Retarded wound healing by U0126 treatment-mediated
cell–cell contact formation
By virtue of a scattered growing pattern and protrusive
morphology of RIE1-Sca cells, their wound healing and cell
migration can consequently be facilitated, as compared with
those of parental RIE1-WT cells. When the wound healing
characteristics of the RIE1 and RIE1-Sca cell lines were
compared, RIE1-Sca cells were found to move into the middle
of wounds faster than the parental RIE1 cells (Fig. 2A),
although cell numbers after the wound healing assay showed no
significant difference (data not shown). Since RIE1-Sca cells
healed wounds faster than parental RIE1 cells, U0126
treatment-mediated cell–cell contact formation might retard
cell movement. Therefore, we examined the wound healing
properties of RIE1-Sca cells before and after U0126 treatment.
To minimize the effects of differences in proliferation rates in
the absence versus presence of U0126 treatment on the degree
of wound healing, wound healings were analyzed for a short
period of 6 h. RIE1-Sca cells healed wounds efficiently even
after 6 h, but U0126-treated RIE1-Sca cells were less efficient
(Fig. 2B). These differences in wound healing rates appeared to
be correlated with U0126-mediated cell–cell contact formation
(Fig. 2C). When cortical actin organization and ZO1-containing
cell–cell contacts were visualized, RIE1-Sca cells with well-
organized cortical actin filaments were found to be separately
oriented toward wounds and cell–cell contacts with ZO1 were
not formed, indicating that scattered cells orientated and
crawled efficiently toward wounds (Fig. 2C, upper). However,
U0126-treated RIE1-Sca cells formed cell–cell contacts with
ZO1 and cortical actin fibers (Fig. 2C, lower), which
presumably reduced wound healing efficiency.
3.3. U0126 treatment-mediated EGFR phosphorylation
When we analyzed for signaling molecules involved in the
U0126 treatment-mediated formation of cell–cell contacts and
retardation of wound healing by using whole cell extracts
prepared from RIE1 cells with or without U0126 treatment,
EGFR was found to be influenced by U0126 treatment; when
cells were treated with U0126, RIE1-Sca cells increased
phosphorylations of EGFR Tyr992, Tyr1068, and Tyr1173
(i.e., pY992EGFR, pY1068EGFR, and pY1173EGFR, respec-
tively), whereas RIE1 WT cells showed a slightly reduced
pY992EGFR but no significant changes in pY1068EGFR or
Fig. 1. U0126 treatment-mediated formation of cell–cell contacts in RIE1-Sca cells. (A) Parental RIE1 wildtype cells and its scattered variant RIE1-Sca cells in 60-mm
culture dishes or serum-containing culture media-precoated coverglasses at subconfluence were imaged or stained for actin by using phalloidin-conjugated TRITC. (B)
RIE1-WTor -Sca cells were treated with 20 μMU0126 for 14 h, prior to harvests of whole cell lysates. Lysates were normalized and used in immunoblots for indicated
molecules. (C) Vehicle DMSO or U0126 at 20 μMwere treated to sub-confluent RIE1-Sca cells for 14 h, prior to taking images. (D) RIE1-Sca cells were replated onto
glass coverslips precoated with serum-containing normal culture media. After cells became confluent, DMSO or U0126 were treated for 14 h. After treatment, cells
were processed for immunofluorescent staining for ZO1 (upper) or β-catenin (lower), as explained in Materials and methods. (E and F) Whole cell lysates were
prepared from cells treated with DMSO or 20 μMU0126, as explained above, and used in standard Western blots by using antibodies against the indicated molecules.
AG1478 was pretreated 30 min before 20 μM U0126 treatment for 14 h (E). The data shown are representative of 3 isolated experiments.
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Cbl binding [18] was decreased in RIE1-Sca, but not in RIE1-
WT cells after U0126 treatment (Fig. 3A). These U0126-
mediated effects were also observed when RIE1-Sca cells were
treated with another MEK inhibitor, PD98059 (data not shown).
These increases in EGFR phosphorylation in U0126-treated
RIE1-Sca cells appeared to be dependent on EGFR kinase
activity, since pretreatment with AG1478 (a specific EGFR
kinase inhibitor) prior to U0126 treatment abolished U0126-
enhanced EGFR phosphorylations including pY1173EGFR and
pY1068EGFR (Fig. 3B and data not shown). In addition,AG1478-pretreatment also blocked the U0126-mediated for-
mation of cell–cell contacts, since β-catenin located more
distally from the plasma membrane after AG1478 pretreatment
(Fig. 3C). In addition, AG1478 pretreatment blocked the U0126
treatment-mediated decrease in vimentin level in RIE1-Sca cells
(Fig. 1E, lanes 2 to 4). Interestingly, U0126 treatment for a short
period (i.e., 2 h) caused EGFR phosphorylation (Fig. 3B, lanes
1 and 3), and this was abolished by pretreatment of EGFR
kinase inhibitor (Fig. 3B, lanes 3 and 5). However, this short
U0126 treatment did not cause cell–cell contact formation (data
not shown). This indicates that Erk1/2 inhibition by U0126
Fig. 2. U0126 treatment-mediated cell contact formation appeared to retard
wound healing. (A and B) Confluent RIE1 WT or RIE1-Sca cells in 60 mm
culture dishes were wounded by scraping through the cell monolayer with a
yellow pipette tip. Cells were then washed twice with DMEM-H containing 10%
FBS. DMSO or U0126 (20 μM) were treated immediately after wounding and
washing cells. Twenty (A) or 6 h (B) later, phase contrast images were taken.
Dotted lines indicate the start lines of wound healings. (C) RIE1-Sca cells were
seeded onto cover glasses precoated with 10% FBS-containing normal culture
media. When cells were confluent, wounds were made through monolayers
using a yellow pipette tip. Cells were then washed twice with the culture media
and immediately treated with DMSO or U0126 (20 μM). Fourteen hours later,
cells were stained for actin (left) or immunostained for ZO1 (right), as explained
in Materials and methods. Arrows indicate wounds centers. The data shown
represent 3 independent experiments.
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between RIE1-Sca cells, and that EGFR phosphorylation
kinetically preceded cell–cell contact formation, when RIE1-
Sca cells were treated with U0126.
3.4. Down-regulation of the Ras/Erks cascade was required for
EGFR phosphorylation and cell–cell contact formation
To determine if the effects of U0126 treatment are caused by
inhibition of specifically Ras/Raf1/Mek/Erks cascade, we
altered activity of this cascade in RIE1-Sca cells prior to
analyzing EGFR phosphorylation and cell–cell contact forma-
tion, by using retroviruses coding for active or dominant
negative H-Ras mutant (H-Ras V12 or N17, respectively, Fig.
4A). RIE1-Sca cells were first infected with retroviruses
expressing active H-Ras V12, which caused the activation of
Erk1/2 but not of Akt/PKB (Fig. 4A, left). Cells were then
treated with DMSO or U0126 for 14 h, and then immunostained
for cell–cell contact markers. RIE1-Sca cells did not form cell–
cell contacts by H-Ras V12 expression alone (Fig. 4B, left).
However, U0126 treatment formed cell–cell contacts in bothcontrol and H-Ras V12-expressing RIE1-Sca cells (Fig. 4B,
right). We then knocked-down Ras/Erks cascade activity using
retrovirus expressing dominant negative H-Ras N17, in stead of
U0126 treatment. RIE1-Sca cells infected with H-Ras N17
retrovirus, but not with control virus, formed cell–cell contacts
with ZO1 and β-catenin (Fig. 4C). Furthermore, the expression
of H-Ras N17 reduced Erk1/2 phosphorylation but increased
EGFR Tyr1173 phosphorylation (Fig. 4D). These observations
indicate that indeed the Ras/MEK/Erks cascade inhibited by
U0126 treatment appeared to cause cell–cell contact formation
involving EGFR phosphorylation.
3.5. EGFR Y5F expression abolished cell–cell contact
formation mediated by U0126 treatment
Next we examined the significance of EGFR phosphoryla-
tion in U0126 treatment-mediated cell–cell contact formation.
RIE1-Sca cells were infected with retrovirus coding for a
nonphosphorylatable mutant of EGFR (EGFR Y5F; Tyr992/
1068/1086/1148/1173Phe, [16], Fig. 5B). Twelve hours after
infection, media were changed with normal culture media. After
an additional 22 h of incubation, cells were treated with DMSO
or U0126 for 14 h prior to immunostaining for cell–cell contact
markers. Interestingly, the expression of EGFR Y5F alone in
RIE1-Sca cells did not form cell contacts (Fig. 5A, upper
panels). Moreover, U0126 treatment-dependent formation of
contacts between RIE1-Sca cells was abolished by EGFR Y5F
expression (Fig. 5A, lower panels), indicating that U0126
treatment-mediated phosphorylations of EGFR are required for
U0126-mediated contact formation.
3.6. U0126-mediated EGFR phosphorylation is independent of
ligand EGF binding
We then wondered whether the U0126-mediated formation
of cell–cell contacts via EGFR phosphorylation depends on
ligand (i.e., EGF) binding. To answer this, we first performed
experiments in the absence of serum. Even in the absence of
serum, treatment with U0126 for 14 h, but not with DMSO,
resulted in the formation of cell–cell contacts with ZO1 (Fig.
6A, left and middle). On the other hand, U0126 cotreatment
with EGF (50 ng/ml) did not cause any significant difference in
cell–cell contact formation. As was expected, U0126-treated
RIE1-Sca cells in the absence of serum showed increased EGFR
phosphorylation (Fig. 6C, middle panels). These findings
indicate that the U0126-mediated formation of cell–cell
contacts occurs via ligand-independent EGFR phosphorylation.
To confirm this alternatively and to rule out the autocrine
possibility, we preincubated cells with neutralizing anti-EGF
antibody prior to U0126 treatment. In the presence of normal
serum-containing culture media, cells were preincubated with
control normal rabbit IgG or neutralizing anti-EGF 60 min prior
to DMSO or U0126 treatment for 14 h. In the presence of
control normal IgG, U0126 treatment caused cell–cell contact
formation, as was shown earlier (Figs. 1D, 3C, 4B, 5A, and lefts
of 6B). Interestingly, U0126-mediated cell–cell contact forma-
tion and EGFR phosphorylation were obvious even in the
Fig. 3. Signaling activities involved in U0126 treatment-mediated contact formation of RIE1-Sca cells. (A and B) Whole cell lysates prepared from cells treated with
DMSO or U0126 (20 μM) for 14 h in the absence (A) or presence of AG1478 pretreatment (2 h prior to U0126 treatment, B) were immunoblotted for the indicated
molecules. (C) RIE1-Sca cells on glass coverslips under normal serum-containing culture conditions were pretreated with 1 μM AG1478, 2 h before 20 μM U0126
treatment for 14 h (AG1478+U0126). Cells were then immunostained for β-catenin (D). The band intensity ratio between experimental conditions (A) is measured by
a densitometer and shown as following; 4.56, 1.23, 1.0, and 5.12 (from lanes 1 to 4, respectively) for pY992EGFR, 0.08, 1.1, 1.0, and 0.09 for pY1045EGFR, 2.1, 2.82,
1.0 and 2.04 for pY1068EGFR, 3.02, 1.97, 1.0, and 5.4 for pY1173EGFR. The data shown are representative of 3 different experiments.
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observations also support that U0126-mediated formation of
cell–cell contacts requires ligand-independent EGFR phosphor-
ylation, suggesting that regulation of intracellular signaling
caused EGFR phosphorylation upon U0126 treatment.
3.7. Inhibition of EGFR phosphorylation affects wound healing
mediated by U0126 treatment
We observed above that U0126 treatment caused cell–cell
contact formation and retarded wound healing (Fig. 2). In
addition, treatment with AG1478, which inhibited EGFR
phosphorylation, abolished U0126-mediated cell–cell contact
formation (Fig. 3C). It is thus likely that the inhibition of
U0126-mediated EGFR phosphorylation facilitates wound
healing. To test this, we examined the effects of AG1478
pretreatment on U0126 treatment-mediated wound healing of
RIE1-Sca cells. In a dose- and time-dependent manner,
AG1478 pretreatment prevented the U0126 treatment-
mediated retardation of the wound healing abilities of RIE1-
Sca cells (Fig. 7A). Furthermore, the expression of H-Ras
N17 retarded the wound healing of RIE1-Sca cells even
without U0126 treatment (Fig. 7B), in the same manner as
U0126 treatment-retarded wound healing (Fig. 2A). On theother hand, the expression of nonphosphorylatable EGFR
(EGFR Y5F) did not retard the wound healing mediated by
U0126 treatment (Fig. 7C), presumably because the nonpho-
sphorylation of EGFR prevented cell–cell contact formation
even after U0126 treatment.
4. Discussion
In this study, inhibition of the Ras/Erks cascade increased
phosphorylation levels of EGFR, subsequently caused cell–cell
contact formation, and inhibited the migratory properties of
RIE1-Sca cells. It has previously been reported that Erks
activity can negatively regulate EGFR signaling activity,
including its tyrosine phosphorylation [19–22], but the
biological significance of such a negative feed-back loop
between Erks and EGFR was limited to cell proliferation. Thus,
the present study provides evidence for the first time that Ras/
Erks cascade inhibition-enhanced EGFR phosphorylation levels
are involved in cell–cell contact formation and wound healing.
A negative feed-back linkage between Erks and EGFR has
been reported to occur through FRS2 (fibroblast growth factor
receptor substrate 2) [20–22]. FRS2α/SNT-1 is heavily
phosphorylated in Ser/Thr and Tyr residues by various stimuli,
and binds to both EGFR via its phosphotyrosine binding (PTB)
Fig. 4. Regulation of the Ras/Raf-1/MEK/Erks cascade via Ras mutant expression affected cell–cell contacts. RIE1-Sca cells were infected with retroviruses
expressing control pLNCX plasmid (Retro-Cont), pLNCX-human H-Ras V12 (Retro-V12) or N17 (Retro-N17) mutants for 12 h. After an additional normal culture
for 22 h, DMSO or U0126 (20 μM) were treated for 14 h before preparation of cell lysates (A) or immunostaining for β-catenin (B and upper panels of C) or ZO1 (C,
lower panels), as explained in Materials and methods. (D) Whole cell lysates were prepared from cells infected with control (Retro-Cont) or H-Ras N17 (Retro-N17)
retroviruses as detailed above, prior to immunoblottings against the indicated molecules. Data shown are representative of 3 independent experiments. ‘Retro-’
indicates retrovirus expressing the indicated molecules.
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1 transduces signals mediated by liganding of various growth
factor receptors including EGFR. Upon EGF stimulation of the
human epidermoid carcinoma A431 cells as well as in stable
NIH3T3/EGFR transfectants, Erk1/2 are activated and phos-
phorylate FRS2α/SNT-1 on Ser/Thr residues, with leading to a
decrease in its tyrosine phosphorylation. Consequently tyro-
sine-phosphorylated FRS2α/SNT-1-mediated growth factor
signaling is curtailed [20]. However, FRS2α/SNT-1 appears
not to be involved in cell–cell contact formation via Ras/Erks
inhibition-induced EGFR phosphorylation of RIE1-Sca cells,
since the tyrosine-phosphorylation of FRS2α/SNT-1 was
unchanged by U0126 treatment (data not shown) and since
U0126 treatment-mediated EGFR phosphorylation and cell–
cell contact formation were ligand-independent. Meanwhile,
FRS2β/SNT-2 is not tyrosine-phosphorylated and binds to Erk2
and constitutively to EGFR [21]. Activated Erk causes down-
regulation of EGFR/Ras/Erk pathway via formation of the
FRS2β/SNT-2-Erk2 complex and down-regulation of EGFR
activation, presumably either by physical perturbation of
autophosphorylation or by mediation of tyrosine phosphatase
[22]. Although it is unclear at this time how Ras/Erk cascadeinhibition causes EGFR phosphorylation in this study, it is
being investigated for another upcoming study.
This study showed that U0126 treatment of RIE1-Sca cells
decreased pY397FAK and pY416c-Src, which is consistent with
previous reports that FAK and c-Src family kinase are involved
in loss of cell–cell contacts [6]. However, FAK phosphoryla-
tions at other tyrosine residues of pY577FAK, pY861FAK, and
pY925FAK in RIE1-Sca cells were not significantly changed,
unlike those observed in RIE1-WT cells after U0126 treatment.
Previous studies have indicated that pY925FAK is correlated
with the disassembly of cell–cell contacts in certain systems.
Whereas pY397FAK and pY861FAK, but not pY925FAK, in
HeLa cells correlated with cell–cell contact formation [23],
active c-Src-mediated pY925FAK in KM12C colon cancer cells
caused the disassembly of cell–cell contacts [23,24]. However,
we observed in this study that pY925FAK appeared not to be
involved in U016 treatment-mediated cell–cell contact forma-
tion, since pY925FAK was not significantly changed by U0126
treatment. Instead, pY397FAK and pY416Src were concomi-
tantly decreased and this was correlated with cell–cell contact
formation after U0126 treatment. Therefore, observations from
these previous studies and the present study indicate different
Fig. 5. Expression of EGFRY5F in RIE1-Sca cells abolished U0126-mediated cell contact formation. RIE1-Sca cells on glass coverslips or on 60-mm culture dishes
were infected with either control retrovirus (Retro-Cont) or retrovirus expressing EGFRY5F (Retro-Y5F), in which the 5 autophosphorylation tyrosine residues were
mutated to phenylalanines to be nonphosphorylatable. After an infection period of 12 h and an additional normal culture for 22 h, cells were treated with DMSO or
U126 (20 μM) for 14 h, prior to processing for immunofluorescent staining for β-catenin (A, lefts) or ZO1 (A, rights) or harvest of cell lysates for immunoblottings
against the indicated molecules (B). Data shown are representative of 3 isolated experiments.
840 E.-S. Kang et al. / Biochimica et Biophysica Acta 1773 (2007) 833–843significance of FAK phosphorylation at distinct tyrosine
residues during regulation of cell–cell contacts.
On the other hand, RIE1-Sca cells significantly increased
pY992EGFR, pY1068EGFR, and pY1173EGFR, and decreased
pY1045EGFR, whereas RIE1-WT cells non-significantly
altered pY1045EGFR and pY1068EGFR and slightly reduced
pY992EGFR and pY1173EGFR, after U0126 treatment.
pY992EGFR is known to recruit protein tyrosine phosphatase
(PTP 1B, PTP 2C, or SHP-2) or PLCγ; pY1068EGFR recruits
Grb2 and/or Shc; and pY1173EGFR recruits Grb2, Shc, SHP-1,
or PLCγ [25]. pY1045EGFR is known to recruit Cbl for EGFR
degradation [18], and thus could be oppositely regulated as
compared with other EGFR autophosphorylation sites for
stimulatory intracellular signaling pathways. Phosphorylated
EGFR has previously been shown to localize at cell–cell
contact sites, with forming a complex with integrin α2β1,
although the biological significance of this localization and
complex formation have not been clarified [26]. In addition,
both EGFR and E-cadherin were shown to locate at the cell–
cell contacts in A431 cells [27] and HaCat keratinocyte cells
[28]. In A431 cells, EGF induced tyrosine phosphorylation
and relocalization of ZO1 from cytosol to tight junction-like
areas in an actin cytoskeleton-dependent manner [29]. EGF
treatment of TMK-1 gastric cancer cells also showed the
localizations of ZO1 and occludin to cell–cell contact sites of
tight junctions in a PKC-dependent manner [30]. It appears
that Ras/Erks cascade inhibition-mediated EGFR phosphor-ylation is required for cell–cell contact formation in the RIE1
system, but that the phosphorylation of EGFR alone is
insufficient, since we observed that U0126 treatment for 2 h
caused EGFR tyrosine phosphorylation but not cell–cell
contact formation. In addition, Ras/Erks inhibition-mediated
EGFR phosphorylation and cell–cell contact formation
occurred even without ligand binding. Thus, it is likely that
U0126 treatment-mediated EGFR phosphorylation without
ligand binding may cause biochemical processes to form cell–
cell contacts, although it remains to be determined how
U0126 treatment-mediated (individual) EGFR tyrosine-phos-
phorylation is important for cell–cell contact formation. It
cannot be ruled out that Ras/Erks cascade inhibition-mediated
EGFR phospho-tyrosines may recruit SH2 domain-containing
molecules during formation of cell–cell contacts.
Previous studies have shown a correlation between EGFR
activation and E-cadherin-mediated cell–cell contacts [31–
34]. EGFR was found to interact and phosphorylate β-catenin
of the cadherin–catenin complex [34] and to directly down-
regulate cell–cell contacts by modulating the linkage of E-
cadherin/catenin complex to the actin cytoskeleton [35]. It
was also previously reported that cadherin-dependent cell
contact formation resulted in Rac1 activation through EGFR
signaling [36] and Erk1/2 activation via the recruitment and
activation of EGFR [28]. However, other controversial studies
previously evidenced that E-cadherin-mediated cell contacts
also inhibited receptor tyrosine kinases including EGFR [37]
Fig. 6. U0126-mediated EGFR phosphorylation and cell–cell contact formation occur in a ligand-independent manner. (A and left/middle panels of C) Serum was
removed from cell cultures prior to the DMSO or U0126 treatment without (U0126) or with EGF (50 ng/ml, U0126+EGF). Treatments were continued for 14 h prior
to immunofluorescent staining for ZO1 (A) or cell lysates harvests for immunoblottings (C, left and middle panels). (B and right panels of C) Cells on either 60-mm
culture dishes or coverglasses were preincubated with normal IgG or anti-EGF (10 μg/ml) 60 min before DMSO or U0126 treatment for 14 h. After incubations, the
cells were processed for ZO1 immunofluorescent staining (B) or harvested for whole cell lysates and then immunoblottings (C, right panels). The data shown represent
3 independent experiments.
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studies presumably indicate that the co-relationship between
EGFR and cadherin-dependent cell contacts may be depen-
dent on their cell surface expression levels and on differential
downstream signaling contexts due to different cell types.
Meanwhile, in the present study, we observed that Ras/Erks
cascade inhibition-mediated formation of cell–cell contacts
required an increase in the phosphorylation of EGFR, based
on experiments with either EGFR kinase inhibitor pretreat-
ment or expression of nonphosphorylatable EGFR Y5F. We
also observed that the expression of EGFR Y5F alone in
RIE1-Sca cells did not form cell contacts, unlike certain
previous studies [34,35]. Therefore, these previous and
current observations indicate that EGFR phosphorylation can
have different effects on cell–cell contacts depending on cell
systems.Cell–cell contacts together with integrin-extracellular matrix
(ECM) interaction and growth factor receptor signaling path-
ways have been suggested to be an integral part of the
morphogenetic programs of cells that control the maintenance
of the structural and functional integrity of epithelia [28,39].
Integrin-mediated cell adhesion signaling appears to be
involved in the regulation of cell–cell contact status, indicating
the presence of cross-talk between cell adhesion receptors;
integrin α6β4 or α2β1 was shown to be involved in EMT of
colon and rat bladder carcinoma cells, respectively [40,41].
Therefore, information on cell–cell contacts may be linked to
integrin-ECM engaging sites (i.e., focal adhesions and con-
tacts), which are dynamically modulated during cell migration.
Abnormal functional integrity of epithelia via the disruption of
cell–cell contacts can allow the dissemination of migratory cells
from (cancer) cell colonies. During the dissemination, integrin
Fig. 7. Regulation of U0126 treatment-mediated signaling activities affects wound healing. (A) RIE1-Sca cells were seeded and wounded with or without treatments of
pharmacological inhibitors, as explained in Materials and Methods. Fourteen or 18 h after wounding and treatment, phase contrast images were taken. Dotted lines
indicate the starting lines for wound healings of a representative experiment. ⁎ and ⁎⁎ indicate statistic significance, as compared to DMSO treatment for 14 h
(⁎p<0.001) and with U0126-alone treatment for 14 h (⁎⁎p<0.05), respectively. (B and C) Cells in 60 mm culture dishes were infected with retrovirus for empty
pLNCX (Retro-Cont), pLNCX-H-Ras N17 (Retro-N17), or pLNCX-EGFRY5F (Retro-Y5F) plasmids for 12 h. After an additional incubation for 22 h, confluent cells
were then wounded and washed, and cell images around wounds were taken at the indicated times (B) or at 14 h post-wounding (C). The dotted lines are start lines.
Representative wound distances were measured for graphic presentations, and higher bars represent less wound healing. ⁎ and ⁎⁎ in (B) indicate statistic significance
(p<0.001), as compared with 10 h wound healing analysis of control-virus infected cells. ⁎ or ⁎⁎ in (C) also indicate statistic significance, as compared with control
virus-infected cells treated with DMSO (⁎p<0.001), or with control virus-infected cells treated with U0126 (⁎⁎p<0.001), respectively. The data shown are
representative of three independent experiments.
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dynamically modulated. Although we did not define the
involvement of integrins in the system, we observed that Ras/
Erks inhibition caused the maintenance of cell–cell contacts
between RIE1-Sca cells crawling towards wound centers and
consequently retarded wound healing. This correlation between
cell–cell contact formation and retarded wound healing may
reflect the functional significance of Ras/Erks cascade inhibi-
tion-mediated cell–cell contact formation. Thus, we suggest
that cell–cell contact status can be regulated by modulating Ras/
Raf1/Mek/Erks cascade activity via diverse mechanismsincluding the loss of integrin–ECM interactions or changes in
the cell surface expressions of growth factor receptors under
both physiologic and pathologic conditions, such as, during
development or tumor metastasis.
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